Conference Coverage

EADV: Pediatric psoriasis called ‘grossly undertreated’


 

EXPERT ANALYSIS FROM THE EADV CONGRESS

References

Dr. Papp and Dr. Langley have served as principal investigators of numerous clinical trials for and served as advisors to pharmaceutical companies developing dermatologic medications.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

EADV: Investigational biologic rocks psoriasis world
MDedge Rheumatology
EADV: Ixekizumab promising for psoriatic arthritis
MDedge Rheumatology
EADV: Long-term apremilast results show what to expect for psoriasis
MDedge Rheumatology
EADV: Spotlight on alexithymia in psoriasis
MDedge Rheumatology
VIDEO: MMF equals cyclophosphamide’s efficacy in sclerodermal lung disease
MDedge Rheumatology
Shingles vaccine protection lasted 5-6 years in autoimmune disease patients
MDedge Rheumatology
Stroke risk rose in autoimmune disease patients after herpes zoster
MDedge Rheumatology
Can bariatric surgery ease psoriasis too?
MDedge Rheumatology
VIDEO: Psoriasis, psoriatic arthritis improve with bariatric surgery
MDedge Rheumatology
ACR: Cardiovascular risk factors in psoriatic diseases are common, often go untreated
MDedge Rheumatology